Sector News

Merck KGaA’s net profit drops sharply on impairments, other expenses; acquisitions boost revenue

August 6, 2020
Chemical Value Chain

Merck KGaA (Darmstadt, Germany) says its net profits in the second quarter of 2020 dropped 38.5% year on year (YOY), to €290 million ($343 million), despite revenue growing 3.7% YOY, to €4.12 billion, driven primarily by acquisition-related growth in the performance materials business and organic growth in the life-science business.

The fall in profits is attributed mainly to impairment losses on intangible assets in performance materials, higher interest expenses, and other operating expenses, the company says. EBITDA and EBIT fell by 2.5% and 20.6%, to €1.05 billion and €491 million, respectively, Merck says.

“Despite considerable pandemic-related obstacles in some businesses, overall we did well in the second quarter. In recent months, we again proved the strengths of our diversified business model with three strong innovation-driven business sectors,” says Stefan Oschmann, chairman and CEO at Merck.
The company’s healthcare business recorded a 10.6% YOY drop in sales, to €1.50 billion, due to the impact of COVID-19, and negative currency and portfolio effects. Fertility was the segment hurt the most by the pandemic, with an organic decrease in sales of 38.9%, Merck says. EBITDA was down 31.3% YOY, to €359 million.
Life-science sales rose by 5.9% to €1.81 billion, with the process solutions segment the key growth driver due to continued high demand in the underlying business, but also as a result of increased orders in the course of the pandemic that drove 19.8% organic growth in sales, Merck says. However, sales of the research solutions segment declined 7.1% and remained flat in the applied solutions segment, the company says. EBITDA jumped 12.8% YOY, to €584 million, it says.

Merck’s performance materials business recorded a 38.1% YOY increase in sales, to €814 million, with a 50.1% sales contribution from the acquisitions of Versum Materials and Intermolecular driving the growth, the company says. The display solutions and surface solutions segments posted lower sales by 20.8% and 29.6%, respectively. Meanwhile, organic sales growth of the semiconductor solutions segment was 12.1%. The performance materials business’s EBITDA rose 35.9% YOY, to €219 million.

Merck has confirmed the assumptions it made, following the COVID-19 outbreak, in a forecast made on 31 March. The company continues to assume that its businesses will be impacted to varying degrees. For full-year 2020, it expects slight-to-moderate organic net sales growth compared with the previous year with sales between €16.9 billion and €17.7 billion. The company continues to expect that life sciences will be a major driver of its organic growth, healthcare will see a slight organic increase in net sales, and that the performance materials business will see a moderate-to-strong organic decline in net sales.

Merck has also raised the lower end of its expected full-year range for EBITDA before exceptional items and now forecasts slight-to-moderate organic growth to €4.45-4.85 billion. It expects strong organic growth in life sciences and a stable development in healthcare, but forecasts an organic decline in performance materials.

By: Sotirios Frantzanas

Source: Chemical Week

comments closed

Related News

May 15, 2022

New York’s EPR and packaging reduction bills lauded as game-changers in plastic pollution battle

Chemical Value Chain

The US State of New York is introducing two new bills to combat over-packaging, poor recycling rates and litter issues, including an Extended Producer Responsibility (EPR) program requiring companies such as McDonald’s and Amazon to pay for the cost of packaging disposal and recycling.

May 15, 2022

Borealis and Reclay launch entity focused on lightweight packaging 

Chemical Value Chain

The new organization’s mission is to redesign the critical steps of the plastics sorting and recycling system for post-consumer lightweight packaging (LWP) to speed up circularity, born from a need to meet the rising market demand for high-quality recyclates for use in high-end plastic applications.

May 15, 2022

Starbucks and Hubbub launch reusable packaging fund as COVID-19 diminishes consumer appetite

Chemical Value Chain

Starbucks and Hubbub have launched a £1 million (US$1.22 million) “Bring It Back Fund” to increase the uptake of reusable packaging in the F&B industry. The funding will go toward innovative ideas that make it easier for customers to use alternatives to single-use packaging by supporting pilot projects that help shift consumption habits.